Microbot Medical Inc.
NASDAQ:MBOTMedical - Instruments & Supplies
-$0.06 today
- Market cap
- $65.73M
- Beta
- 1.04
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.21
Volume 0.87M
Average 1.60M
MBOT Total Non-current Assets
All assets not expected to be converted to cash within one year.
Microbot Medical Inc.NASDAQ: MBOT
Total Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Total non-current assets rises 551.7% from a year ago
Total non-current assets stood at $1.54M at the end of Q1 FY2026, up 551.7% from a year earlier and down 10.7% from the prior quarter. Over 3 fiscal years it compounded at +33.5% a year.
Context
- Total non-current assets amounted to 2.0% of total assets at the end of Q1 FY2026, up 1.2 pp from a year earlier.
- Total non-current assets increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total non-current assets keeps rising in the next quarterly balance sheet after a +551.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 1.72M USD
- Year-over-year change
- +712.3%
- 4-year CAGR
- +18.0%
| Period | Period end | Total Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.72M | +712.3% |
| FY2024 | 2024-12-31 | 212K | -47.8% |
| FY2023 | 2023-12-31 | 406K | -43.8% |
| FY2022 | 2022-12-31 | 723K | -18.6% |
| FY2021 | 2021-12-31 | 888K | — |
Total Non-current Assets vs competitors
How MBOT compares with its peers on the latest reported figures
- Peers report in different currencies, so total non-current assets is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +551.7% is the 2nd highest of 10, against a peer median of -7.8%.
- Total non-current assets amounts to 2.0% of total assets for MBOT, versus a peer median of 38.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $200.7M USD | +1149.4% | +178.2% | 74.7% | |
| Mar 2026 | $71.06M USD | -57.8% | -19.1% | 34.0% | |
| Mar 2026 | $65.48M USD | +83.3% | +36.3% | 29.0% | |
| Mar 2026 | $20.81M USD | +1.0% | +81.4% | 49.1% | |
| Mar 2026 | $19.9M USD | -7.8% | +24.6% | 38.6% | |
| Mar 2026 | CA$12.84M CAD | -8.5% | -5.7% | 84.9% | |
| Mar 2026 | $8.64M USD | -18.8% | -15.7% | 39.9% | |
| Mar 2026 | $1.54M USD | +551.7% | +33.5% | 2.0% | |
| Mar 2026 | $342.28K USD | +45.9% | +7.6% | 0.6% | |
| Mar 2026 | CA$139.33K CAD | -23.7% | -35.3% | 0.4% | |
| Peer median (excluding MBOT) | — | -7.8% | +7.6% | 38.6% | |
Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Microbot Medical Inc.
NASDAQ:MBOT
Intrinsic Alpha fair value
Locked
Current Price
$0.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.